A Mixed-Methods Study of Motives for Benzodiazepine Misuse Among Adults Receiving Substance Use Disorder Treatment
- 26 April 2025
- journal article
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 60 (9) , 1328-1338
Abstract
Benzodiazepine misuse is common among individuals with substance use disorders (SUDs) and is associated with poorer clinical outcomes. As benzodiazepines have heterogeneous effects, standard measures of substance use motives may overlook key reasons for misuse. Understanding motives better can inform intervention development. Our overarching objective was to characterize motives for benzodiazepine misuse among individuals with SUDs and develop a preliminary measure of these motives. We used a two-study, mixed methods design. Participants were recruited from a continuum of SUD treatment programs at a private psychiatric hospital. Study 1 participants (N = 10, 5 women) completed a semi-structured interview regarding motives and triggers for benzodiazepine misuse, and notes from interviews underwent inductive thematic analysis. Results from Study 1 were used to develop the Benzodiazepine Use Motives Questionnaire (BUMQ), which was administered to 38 participants (13 women) in Study 2. Qualitative analysis from Study 1 revealed six themes reflecting motives subtypes for benzodiazepine misuse, including (1) coping, (2) other substance (i.e., non-benzodiazepine) related, (3) sleep, (4) recreational, (5) benzodiazepine withdrawal and habit, and (6) social contextual. Results from Study 2 further supported the misuse of benzodiazepines to cope with negative affect, modulate the effects of non-benzodiazepine drugs, and improve sleep. This study revealed a broad range of benzodiazepine misuse motives in adults with SUDs, spanning misuse for drug-indicated reasons (e.g., anxiety, sleep), compensatory or synergistic effects with other drugs, physiological dependence, and recreational and social reasons. Treatments for benzodiazepine misuse may need to target multiple, varied motivators for misuse.Keywords
Funding Information
- McLean Hospital
- National Institute on Drug Abuse (K23 DA035297, K23 DA050780)
- the Sarles Young Investigator Award and NIDA (K23, 97, 80)
This publication has 42 references indexed in Scilit:
- A pilot study of benzodiazepine cue-induced cravingDrug and Alcohol Dependence, 2022
- High prevalence of co-occurring substance use in individuals with opioid use disorderAddictive Behaviors, 2021
- Co-occurring Mood and Substance Use Disorders2020
- The epidemiology of benzodiazepine misuse: A systematic reviewDrug and Alcohol Dependence, 2019
- Review: Adjunctive pharmacologic approaches for benzodiazepine tapersDrug and Alcohol Dependence, 2018
- Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorderAddictive Behaviors, 2017
- A survey of nonmedical use of tranquilizers, stimulants, and pain relievers among college students: Patterns of use among users and factors related to abstinence in non-usersDrug and Alcohol Dependence, 2014
- Treatment or “high”: Benzodiazepine use in patients on injectable heroin or oral opioidsAddictive Behaviors, 2013
- A Motivational Model of Alcohol Use: Determinants of Use and Change2011
- Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluationBehaviour Research and Therapy, 2010